Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Thonhofer

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Molecules (Basel, Switzerland)|October 14, 2020
<i>N</i>-Alkylated Iminosugar Based Ligands: Synthesis and Inhibition of Human Lysosomal β-GlucocerebrosidaseAndreas Wolfsgruber, Martin Thonhofer, Patrick Weber, et al.
Bioorganic & Medicinal Chemistry Letters|June 11, 2017
A new type of pharmacological chaperone for G<sub>M1</sub>-gangliosidosis related human lysosomal β-galactosidase: N-Substituted 5-amino-1-hydroxymethyl-cyclopentanetriolsMichael Schalli, Patrick Weber, Christina Tysoe, et al.
Carbohydrate Research|March 14, 2017
A Morita-Baylis-Hillman based route to C-5a-chain-extended 4-epi-isofagomine type glycosidase inhibitorsRené Lebl, Martin Thonhofer, Christina Tysoe, et al.
Carbohydrate Research|March 21, 2017
N-Substituted 5-amino-1-hydroxymethyl-cyclopentanetriols: A new family of activity promotors for a G<sub>M1</sub>-gangliosidosis related human lysosomal β-galactosidase mutantMichael Schalli, Christina Tysoe, Roland Fischer, et al.
Bioorganic & Medicinal Chemistry Letters|February 4, 2016
Synthesis of C-5a-chain extended derivatives of 4-epi-isofagomine: Powerful β-galactosidase inhibitors and low concentration activators of GM1-gangliosidosis-related human lysosomal β-galactosidaseMartin Thonhofer, Patrick Weber, Andres Gonzalez Santana, et al.
Carbohydrate Research|April 12, 2016
Synthesis of C-5a-substituted derivatives of 4-epi-isofagomine: notable β-galactosidase inhibitors and activity promotors of GM1-gangliosidosis related human lysosomal β-galactosidase mutant R201CMartin Thonhofer, Patrick Weber, Andres Gonzalez Santana, et al.
Carbohydrate Research|June 25, 2025
Stereoselective ring contractions in glycopyranosides as key-step en route to isoiminosugarsAlexander Luttenberger, Elena Spari, André Culum, et al.
Bioorganic Chemistry|September 4, 2023
Highly functionalized diaminocyclopentanes: A new route to potent and selective inhibitors of human O-GlcNAcasePatrick Weber, Zuzana Mészáros, Pavla Bojarová, et al.
Beilstein Journal of Organic Chemistry|May 27, 2010
Synthesis of lipophilic 1-deoxygalactonojirimycin derivatives as D-galactosidase inhibitorsGeorg Schitter, Elisabeth Scheucher, Andreas J Steiner, et al.
Chembiochem : a European Journal of Chemical Biology|September 16, 2023
Ligand-Directed Chemistry on Glycoside Hydrolases - A Proof of Concept StudyHerwig Prasch, Andreas Wolfsgruber, Martin Thonhofer, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Molecules (Basel, Switzerland)|October 14, 2020
<i>N</i>-Alkylated Iminosugar Based Ligands: Synthesis and Inhibition of Human Lysosomal β-GlucocerebrosidaseAndreas Wolfsgruber, Martin Thonhofer, Patrick Weber, et al.
Bioorganic & Medicinal Chemistry Letters|June 11, 2017
A new type of pharmacological chaperone for G<sub>M1</sub>-gangliosidosis related human lysosomal β-galactosidase: N-Substituted 5-amino-1-hydroxymethyl-cyclopentanetriolsMichael Schalli, Patrick Weber, Christina Tysoe, et al.
Carbohydrate Research|March 14, 2017
A Morita-Baylis-Hillman based route to C-5a-chain-extended 4-epi-isofagomine type glycosidase inhibitorsRené Lebl, Martin Thonhofer, Christina Tysoe, et al.
Carbohydrate Research|March 21, 2017
N-Substituted 5-amino-1-hydroxymethyl-cyclopentanetriols: A new family of activity promotors for a G<sub>M1</sub>-gangliosidosis related human lysosomal β-galactosidase mutantMichael Schalli, Christina Tysoe, Roland Fischer, et al.
Bioorganic & Medicinal Chemistry Letters|February 4, 2016
Synthesis of C-5a-chain extended derivatives of 4-epi-isofagomine: Powerful β-galactosidase inhibitors and low concentration activators of GM1-gangliosidosis-related human lysosomal β-galactosidaseMartin Thonhofer, Patrick Weber, Andres Gonzalez Santana, et al.
Carbohydrate Research|April 12, 2016
Synthesis of C-5a-substituted derivatives of 4-epi-isofagomine: notable β-galactosidase inhibitors and activity promotors of GM1-gangliosidosis related human lysosomal β-galactosidase mutant R201CMartin Thonhofer, Patrick Weber, Andres Gonzalez Santana, et al.
Carbohydrate Research|June 25, 2025
Stereoselective ring contractions in glycopyranosides as key-step en route to isoiminosugarsAlexander Luttenberger, Elena Spari, André Culum, et al.
Bioorganic Chemistry|September 4, 2023
Highly functionalized diaminocyclopentanes: A new route to potent and selective inhibitors of human O-GlcNAcasePatrick Weber, Zuzana Mészáros, Pavla Bojarová, et al.
Beilstein Journal of Organic Chemistry|May 27, 2010
Synthesis of lipophilic 1-deoxygalactonojirimycin derivatives as D-galactosidase inhibitorsGeorg Schitter, Elisabeth Scheucher, Andreas J Steiner, et al.
Chembiochem : a European Journal of Chemical Biology|September 16, 2023
Ligand-Directed Chemistry on Glycoside Hydrolases - A Proof of Concept StudyHerwig Prasch, Andreas Wolfsgruber, Martin Thonhofer, et al.
Pageof 3